1Kroot EJ,de Jong BA, van leeuwen MA, etal, The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum, 2000, 43 (8) : 1831-1835.
2Avouac J,Gossec I., Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis:a systematic literature review. Ann Rheum Dis,2006, 65(7) :845-851.
3Felson DT,Anderson JJ,Boers M, et al. The American college of rheumatology preliminary core set of disease activity meas- ures for rheumatoid arthritis clinical trials. The committee on outome measures in rheumatoid arthritis clinical trials. Arthritis Rheum, 1993,36 : 729-740.
5Cannon GW, Holden WL,Juhaeri J,et al. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD. J Rheumatol,2004,31(10) :1906-1911.
1PAULUS HE, SCOTT DL, EDMONDS JP. Classification of antirheumatic drugs: a new proposal[J]. Arthritis Rheum, 1992, 35:364 - 365.
2LEADER. Anti-inflammatory mechanism of methotrexate in rheumatoid arthritis[J]. Ann Rheum Dis, 2001, 61: 729-735.
3WEINBLATT ME, KREMER JM, COBLYN JS. Pharmacokinetic,safty,and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis[J]. Arthritis Rheum, 1999, 42: 1322-1328.
4GOLDMAN FD, GILMAN AD, HOLLENBACK C, et al. Hydroxychloquine inhibits calcium signals in T cell: a new mechanism to explain its immunomodulatory properties[J]. Blood,2000, 95:3460 - 3466.
5LAGNEAUXL L, DELFORGE A, DEJENEFFE M, et al. Hydroxychloquine - induced apoptosis of chronic lymphocytic leukemia activation of caspase- 3 and modulation of Bcl-2/Bax ratio[J]. Leuk Lymphoma, 2002, 43: 1087- 1095.
6MINGHETTI PP, BLACKBURN WD Jr. Effects of sulfasalazine and its metabolites on stead state messenger RNA concentrations for inflammatory cytokines,matrix metalloproteinases, and tissue inhibitors of metalloproteinases in rheumatoid synovia fibroblasts[J]. J Rheumatol, 2000, 27: 653-660.
7RODENBURG RJ, GANGA A, VAN LENT PL, et al. The antiinflammatory drug sulfasalazine inhibits tumor necrosis factor alpha expression in macrophages by inducing apoptosis[J]. Arthritis Rheum, 2000, 43: 1941- 1950.
8SIEMASKO K, CHONG AS, JACK HM, et al. Inhibition of JAK3 and STAT6 tyrosine phosphory by immunosuppress drug:leflunomide leads to a block in IgG1 production[J]. J Immunol,1998, 160: 1581-158.
9VOLIN M, CAMPBELL P, CONNORS M, et al. The effect of sulfasalazine on rheumatoid arthritic synovial tissue chemokine production[J]. Exp Mol Pathol, 2002, 73: 84.
10NOSE M, SASANO M, KAWASHIMA Y. Salazosulfapyridine suppresses chondrocyte mediated degradation induced by interleukin 1 beta[J]. J Rheumatol,1997, 24: 550-554.
6Sokka T,Pincus T.Contemporary disease modifying antirheumatic drugs(DMABD)in patients with recent onset rheumatoid arthritis in a US private practiee:methotrexate as the anchor drug in 90% and new DMARD in 30% of patients[J].J Rheumatol,2002,29(12):2521-2524.
7Felsen DT,Anderson JJ,Boers M,et al,American college of total glueosiders of poeany(TGP)[J].Chin J Pharmacol Toxicol 1990:4(3):190-193.
8Aiber JM,Paimela L,Kurki P,et al.Treatment strategy,disease activity,and outcome in four cohorts with early rheumatoid arthritis[J].Ann Rheum Dis,2001(60):453.
9Calabress LH.Rheumatoid arthritis and primary care:the case for early diagnosis and treatment[J].J Am Osteopath Assoc,1999(11):313.
10Morgan SL,Baggott JE,Vaughn WH,et al.The effect offolic acid supplementation on the toxicity of low-dose methotrexate inpatients with rheumatoid arthritis[J].Arthritis Rheum,1990(33):9-18.
